时代中国控股(01233.HK):部份赎回于2022年到期的优先票据
格隆汇5月28日丨时代中国控股(01233.HK)公布,有关发行于2022年到期的7.625%优先票据。公司于今日宣布,其已知会受托人及2022票据的持有人,本金总额为4亿美元的尚未赎回2022年票据将于2021年6月27日按相等于其本金额的101%另加直至赎回日期(但不包括该日)的应计及未付利息(如有)的赎回价赎回("部份赎回")。
于公告日期,2022年票据的尚未赎回本金额为5亿美元。完成部份赎回后,2022年票据的尚未赎回本金额将为1亿美元。公司将动用内部资金偿付2022年票据的尚未赎回本金额另加应计及未付利息(如有)赎回款项。
待部份赎回后,所有已赎回的2022年票据将予注销。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.